Rapport Therapeutics, Inc.
RAPPNasdaqCIK 2012593HealthcareFiscal year ends Dec 31
All transactions: 7
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-23 | Sanchez RamiroDirector | Purchase | 3,600 | $27.3549 | $98.5k | Form 4 |
| 2026-10-22 | Paul Steven MDirector | Purchase | 35,714 | $27.28 | $974.3k | Form 4 |
| 2026-10-22 | Young Wendy B.Director | Purchase | 3,789 | $26.39 | $100.0k | Form 4 |
| 2026-10-22 | Silva Paul MDirector | Purchase | 3,680 | $27.075 | $99.6k | Form 4 |
| 2026-10-22 | Maraganore JohnDirector | Purchase | 1,172 | $26.9173 | $31.5k | Form 4 |
| 2026-10-22 | Maraganore JohnDirector | Purchase | 8,239 | $26.3799 | $217.3k | Form 4 |
| 2026-10-21 | Ceesay AbrahamChief Executive Officer, Director, Officer | Sale | 2,210 | $29.1618 | $64.4k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 19:33 ET. Listed shows no prices and gives no investment advice.